D
Blueprint Medicines Corporation BPMC
$88.61 -$1.40-1.56%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Revenue 103.41% 126.61% 139.98% 51.87% 85.55%
Total Other Revenue -- -- -- -- --
Total Revenue 103.41% 126.61% 139.98% 51.87% 85.55%
Cost of Revenue 3,363.72% -57.57% 113.47% -28.63% -96.80%
Gross Profit 93.64% 142.73% 141.73% 57.99% 123.77%
SG&A Expenses 21.60% 27.12% 24.20% 17.77% 23.89%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 5.93% -4.52% -2.34% -6.70% -6.11%
Operating Income 60.80% 62.03% 66.37% 36.54% 29.83%
Income Before Tax 55.54% 58.06% 62.37% 169.22% 29.66%
Income Tax Expenses 1,001.64% 38.58% -46.32% -65.38% -94.11%
Earnings from Continuing Operations 54.96% 57.91% 62.35% 168.80% 30.09%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income 54.96% 57.91% 62.35% 168.80% 30.09%
EBIT 60.80% 62.03% 66.37% 36.54% 29.83%
EBITDA 64.08% 64.23% 68.31% 38.59% 27.46%
EPS Basic 56.88% 59.70% 63.75% 167.18% 31.25%
Normalized Basic EPS 45.80% 59.84% 63.76% 36.18% 20.44%
EPS Diluted 56.88% 59.70% 63.54% 164.97% 31.25%
Normalized Diluted EPS 45.80% 59.84% 63.76% 38.40% 20.44%
Average Basic Shares Outstanding 4.45% 4.44% 3.86% 2.42% 1.70%
Average Diluted Shares Outstanding 4.45% 4.44% 3.86% 6.11% 1.70%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings